Winton Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-5,322
| Closed | -$978K | – | 1530 |
|
|
2021
Q2 | $978K | Buy |
5,322
+903
| +20% | +$166K | 0.05% | 541 |
|
|
2021
Q1 | $676K | Buy |
+4,419
| New | +$676K | 0.04% | 708 |
|
|
2020
Q4 | – | Sell |
-13,679
| Closed | -$1.57M | – | 1598 |
|
|
2020
Q3 | $1.57M | Buy |
13,679
+4,766
| +53% | +$545K | 0.05% | 643 |
|
|
2020
Q2 | $1M | Buy |
+8,913
| New | +$1M | 0.03% | 963 |
|
|
2017
Q4 | – | Sell |
-56,599
| Closed | -$7.94M | – | 725 |
|
|
2017
Q3 | $7.94M | Buy |
56,599
+54,164
| +2,224% | +$7.6M | 0.25% | 105 |
|
|
2017
Q2 | $296K | Buy |
+2,435
| New | +$296K | 0.01% | 568 |
|
|
2014
Q3 | – | Sell |
-16,703
| Closed | -$2.61M | – | 689 |
|
|
2014
Q2 | $2.61M | Buy |
+16,703
| New | +$2.61M | 0.02% | 426 |
|